Key statistics
On Friday, Fibrobiologics Inc (SG0:FRA) closed at 3.28, 260.44% above the 52 week low of 0.91 set on Aug 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.28 |
---|---|
High | 3.28 |
Low | 3.28 |
Bid | 3.42 |
Offer | 3.50 |
Previous close | 3.30 |
Average volume | 0.00 |
---|---|
Shares outstanding | 35.16m |
Free float | 26.84m |
P/E (TTM) | -- |
Market cap | 130.79m USD |
EPS (TTM) | -0.939 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 07:00 GMT.
More ▼
Announcements
- FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
- FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024
- FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
- FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office
- FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit
- FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
- FibroBiologics Engages Southern Star Research as CRO in Australia
- FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
- FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
More ▼